CVS vs NTNX · P/E 16, rev $106.10B vs P/E 108, rev $2.54B
CVS Health Corp (CVS) versus Nutanix Inc (NTNX) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Nutanix Inc (NTNX) is a software - infrastructure company listed on US.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported NTNX revenue for 2025-07-31 was $2.54B. Net income was $188.4M. Revenue was up 18.1% from 2024-07-31 to 2025-07-31. NTNX currently screens at market cap $18.74B and trailing P/E 107.6.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. NTNX currently screens at market cap $18.74B and trailing P/E 107.6.
Not investment advice. Open the CVS and NTNX stock pages for the full models.
Not investment advice.